Skip to main content
. Author manuscript; available in PMC: 2023 Jul 1.
Published in final edited form as: Clin Pharmacol Ther. 2022 May 2;112(1):146–155. doi: 10.1002/cpt.2612

Figure 1. Time-to-Event Curves for Atherothrombotic Events.

Figure 1.

A) Major atherothrombotic events (MAE), defined as the first occurrence of death, myocardial infarction (MI), ischemic stroke, stent thrombosis (ST), or unstable angina requiring revascularization at 1-year post-PCI. Adjusted hazard ratio (HR) 1.66 (95% CI, 1.23 – 2.25), p<0.001. B) Major adverse cardiovascular events (MACE), defined as the first occurrence of cardiovascular death, MI, ST, or ischemic stroke at 1-year post-PCI. Adjusted HR 1.59 (95% CI, 1.11 – 2.30), p=0.013. The tails of the Kaplan-Meier curves in Panels A and B were truncated at 360 days post-PCI, after which time less than 10% of each stratum were available for follow-up. In Panel A, n=4 events were observed in the ABCD-GENE score <10 group after day 360, when only 71 (4% of patients with a score <10) patients were still in follow-up. In Panel B, n=1 event occurred after day 360 in the ABCD-GENE score <10 group. No cardiovascular events occurred after day 360 for the ABCD-GENE score ≥10 group when 16 (3%) patients were available for follow-up.